The influences of fenofibrate on levels of tumor necrosis factor-alpha in serum and adipocytes secretion of hypercholesterolemia rabbits

Chinese Pharmacological Bulletin

Volumn 21, Issue 2, 2005, Pages 157-161

  Zhao, Shui Ping ^a   Wu, Jie ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Adipocytes; Fenofibrate; Hypercholesterolemia; TNF

Indexed keywords

CHOLESTEROL; FENOFIBRATE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA;

ADIPOCYTE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL DIET; CONTROLLED STUDY; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; HYPERCHOLESTEROLEMIA; INFLAMMATION; MACROPHAGE; MALE; MONOCYTE; NONHUMAN; OBESITY; RABBIT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 17144397542     PISSN: 10011978     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Garwal BB. Human Cytokines [M]. Boston: Blackwell Scientific Publications, 1992:270.
2. Madej A, Okopien B, Kowalski J et al. Effects of fenofibrate on plasma cytokine concentrations in patients with atherosclerosis and hyperlipoproteinemia II b[J]. Int J Clin Pharmacol Ther, 1998, 36(6):345-54.
3. Sewter CP, Digby JE, Blows F et al. Regulation of tumor necrosis factor-alpha release from human adipose tissue in vitro[J]. J Endocrinol, 1999, 163(1):33-8.
4. Winkler G, Kiss S, Keszthelyi L et al. Expression of tumor necrosis factor (TNF)-alpha protein in the subcutaneous and visceral adipose tissue in correlation with adipocyte cell volume, serum TNF-alpha, soluble serum TNF-receptor-2 concentrations and C-peptide level[J]. Eur J Endocrinol, 2003, 149(2):129-35.
5. Pineda-Torra I, Gervois P, Staels B. Peroxisome proliferator-activated receptor alpha in metabolic disease, inflammation, atherosclerosis and aging[J]. Curr Opin Lipidol, 1999, 10(2):151-9.
6. Guerre-Millo M, Gervois P, Raspe E et al. Peroxisome proliferator- activated receptor α activators improve insulin sensitivity and reduce adiposity[J]. J Biol Chem, 2000, 275(22):16638-42.
7. Rodbell M. Effects of hormones on glucose metabolism and lipolysis[J]. J Biol Chem, 1964, 239(2):375-80.
8. Zhang HH, Kumar S, Barnett AH et al. Ceiling culture of mature human adipocytes: use in studies of adipocyte functions[J]. J Endocrinol, 2000, 164 (2):119-28.
9. Han SN, Leka LS, Lichtenstein AH et al. Effect of hydrogenated and saturated, relative to polyunsaturated, fat on immune and inflammatory responses of adults with moderate hypercholesterolemia [J]. J Lipid Res, 2002, 43(3):445-52.
10. Jovinge S, Ares MP, Kallin B et al. Human monocytes/macrophages release TNF-alpha in response to Ox-LDL[J]. Arterioscler Thromb Vasc Biol, 1996, 16(12):1573-9.
11. Skolnik EY, Marcusohn J. Inhibition of insulin receptor signaling by TNF: Potential role in obesity and non -insulin-dependent diabetes mellitus[J]. Cytokine Growth Factor Rev, 1996, 7 (2):161-73.
12. Marx N, Sukhova GK, Collins T et al. PPAR alpha activators inhibit cytokine-induced vascular cell adhesion molecule-1 expression in human endothelial cells[J]. Circulation. 1999, 99(24): 3125-31.
13. Staels B, Koenig W, Habib A et al. Activation of human aortic smooth-muscle cells is inhibited by PPARalpha but not by PPAR-gamma activators[J]. Nature, 1998, 393 (6687):790-3.
14. Cabrero A, Alegret M, Sanchez RM et al. Bezafibrate reduces mRNA levels of adipocyte markers and increases fatty acid oxidation in primary culture of adipocytes[J]. Diabetes, 2001, 50(8): 1883-90.
15. Hennuyer N, Poulain P, Madsen L et al. Beneficial effects of fibrates on apolipoprotein A-I metabolism occur independently of any peroxisome proliferative response[J]. Circulation, 1999, 99(18): 2445-51.